Cargando…
Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer
The present study explored the use of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer (CRC). Methylated NDRG4 gene expression from colorectal carcinoma tissue, paracarcinoma tissues, stools, blood and urine were detected successfully in DNA samples from 84 patients,...
Autores principales: | XIAO, WENHUA, ZHAO, HUIXIA, DONG, WEIWEI, LI, QUIWEN, ZHU, JIANHUA, LI, GUANGHUI, ZHANG, SHUFANG, YE, MING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315048/ https://www.ncbi.nlm.nih.gov/pubmed/25663916 http://dx.doi.org/10.3892/ol.2014.2815 |
Ejemplares similares
-
Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells
por: Xiao, Wenhua, et al.
Publicado: (2013) -
Gene silencing of heparanase results in suppression of invasion and migration of hepatoma cells
por: Dong, Weiwei, et al.
Publicado: (2014) -
NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients
por: Chu, Dake, et al.
Publicado: (2015) -
NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population
por: Chen, Xiaoying, et al.
Publicado: (2016) -
NDRG2 gene copy number is not altered in colorectal carcinoma
por: Lorentzen, Anders, et al.
Publicado: (2017)